KPF
LENZ

K2 Principal Fund’s LENZ Therapeutics LENZ Stock Holding History

K2 Principal Fund’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-138,517
Closed -$2.38M – 348
2023
Q1 		$2.38M Buy
138,517
+134,456
+3,311% +$2.17M 0.65% 75
2022
Q4 		$94.4K Buy
+4,061
New +$94.1K 0.03% 167
2022
Q3 		– Sell
-57,382
Closed -$1.1M – 409
2022
Q2 		$1.1M Buy
+57,382
New +$1.28M 0.19% 147

Other funds holding LENZ

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return